The announcement coincides with NVIDIA’s expansion of its BioNeMo Cloud service, which aids in generative AI’s application to drug discovery. The new service aids in the development of AI models (and handles inference) that are used to create novel therapeutic proteins and advance disciplines like biology and chemistry. According to NVIDIA, scientists can speed up one of the laborious steps in their pipeline.
